Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC and CBD on Emotional Stimuli Processing
NCT02291536Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dronabinol and cannabidiol in schizophrenia and psychosis, sponsored by Central Institute of Mental Health. Primary endpoint: Correctly identified emotional pictures during the attentional blink period. Started Feb 2014; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
schizophreniapsychosis
Beyond the preview
Go deeper on NCT02291536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291536.